ESMO Events 2025
Meetings Wird in neuem Tab/Fenster geöffnet | ESMO Wird in neuem Tab/Fenster geöffnet
Welcome to our ESMO Virtual Congress site where we showcase the very best from ESMO's flagship portfolio.
ESMO Breast Cancer Congress 2025 Wird in neuem Tab/Fenster geöffnet
Join us at this focused event that will bring together international experts in the field to explore the latest innovations, discuss cutting-edge treatments and collaborate on strategies to improve patient outcomes.
We aim to provide fresh insights into the most recent advancements in breast cancer diagnosis, treatment and survivorship, by offering a comprehensive overview of the current landscape of breast cancer care.
Share experiences, exchange ideas and forge meaningful collaborations with renowned experts in the field.
Below a collection of papers recently published in ESMO’s premier journals carefully selected to reflect the themes of the meeting.
Annals of Oncology
Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC)☆ Wird in neuem Tab/Fenster geöffnet A. Fernandez-Martinez, M. Tanioka, S.G. Ahn, P. Zagami, T. Pascual, M. Rediti, G. Tang, K.A. Hoadley, D. Venet, N.U. Rashid, P.A. Spears, S. Di Cosimo, E. de Azambuja, A. Choudhury, P. Rastogi, M.N. Islam, J. Cortes, A. Llombart-Cussac, S.M. Swain, C. Sotiriou, A. Prat, C.M. Perou, L.A. Carey
TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy☆ Wird in neuem Tab/Fenster geöffnet M. Martín, S.R. Stecklein, O. Gluz, G. Villacampa, M. Monte-Millán, U. Nitz, S. Cobo, M. Christgen, F. Brasó-Maristany, E.L. Álvarez, I. Echavarría, B. Conte, S. Kuemmel, C. Bueno-Muiño, Y. Jerez, R. Kates, M. Cebollero, C. Kolberg-Liedtke, O. Bueno, J.Á. García-Saenz, F. Moreno, E.-M. Grischke, H. Forstbauer, M. Braun, M. Warm, J. Hackmann, C. Uleer, B. Aktas, C. Schumacher, R. Wuerstleins, M. Graeser, C. zu Eulenburg, H.H. Kreipe, H. Gómez, T. Massarrah, B. Herrero, L. Paré, U. Bohn, S. López-Tarruella, A. Vivancos, E. Sanfeliu, J.S. Parker, C.M. Perou, P. Villagrasa, A. Prat, P. Sharma, N. Harbeck
ESMO Open
Differential benefit of adjuvant everolimus according to endocrine therapy backbone in the randomized UNIRAD trial Wird in neuem Tab/Fenster geöffnet M. Saint-Ghislain, S. Chabaud, F. Dalenc, D. Allouache, D. Cameron, M. Martinez, J. Grenier, P. Barthelemy, M. Brunt, L. Kaluzinski, A. Mailliez, E. Legouffe, A.-C. Hardy-Bessard, S. Giacchetti, M.-A. Mouret-Reynier, J.-L. Canon, J. Bliss, J. Lemonnier, F. Andre, T. Bachelot, P. Cottu
Refining prognostic tools for luminal breast cancer: genetic insights and comprehensive analysis Wird in neuem Tab/Fenster geöffnet L.A. Sinberger, T. Zahavi, N. Keren-Khadmy, Y. Dugach, A. Sonnenblick, M. Salmon-Divon
Immuno-Oncology and Technology
Assessment of CD73 activity in breast cancer-derived small extracellular vesicles: application to monitoring of patients’ responses to immunotherapy Wird in neuem Tab/Fenster geöffnet T.L. Whiteside, S. Sehra, T. Chadderton, M. Guha, M.C. Stubbs, C. Timmers, E.K. Jackson
Potentiating intratumoral therapy with immune checkpoint inhibitors: shifting the paradigm of multimodality therapeutics Wird in neuem Tab/Fenster geöffnet B.E. Nelson, A. Naing, S. Fu, R.A. Sheth, R. Murthy, S. Piha-Paul
ESMO Real World Data and Digital Oncology
Clinical decision impact of HER2DX, an algorithm-powered genomic diagnostic in early-stage HER2-positive breast cancer: results from a prospective real-world study Wird in neuem Tab/Fenster geöffnet O. Martínez-Sáez, M. Tapia, M. Marín-Aguilera, E. Hernández-Illán, C. Tébar, A.I. Martinez-Puchol, P. Jares, S. Marín-Liébana, A. Magro, J.A. Puig-Butille, L. Palomar, E. Sanfeliu, M.T. Martinez, M.V. Losada, C. Hernando, B. Adamo, V. Iranzo, T. Pascual, A. Pouptsis, F. Schettini, A. Santaballa, B. Conte, M.D. Torregrosa, F. Brasó-Maristany, B. Walbaum, R. Gómez-Bravo, O. Burgués, I.G. Fructuoso, I. Garrido-Cano, E. Seguí, L. Paré, M. Muñoz, E. Carcelero, J. Sànchez, P. Villagrasa-González, W. Buckingham, A. Prat, G. Villacampa, N. Chic, P. Rivera, A. Rezqallah, C. Saura, S. Escrivà, B. Bermejo, A. Lluch, A. Llombart, J.M. Cejalvo
ESMO affiliated journals
An international Phase IV field study - psychometric properties of the updated module on assessing quality of life of patients with breast cancer EORTC QLQ-BR42 Wird in neuem Tab/Fenster geöffnet Vesna Bjelic-Radisic, Fatima Cardoso, Joachim Weis, Katarzyna Pogoda, Juan Ignacio Arraras, Elfriede Greimel, Andrew Bottomley, David Cameron, Etienne Brain, Sue Hartup, René Aloisio da Costa Vieira, Nicolette Hoefnagels, Chi-Cheng Huang, Omar Shamieh, Monica Pinto, Yared Belete Belay, Samantha Serpentini, Eveline Bleiker, Manjunath Nookala Krishnamurthy, Akihiko Shimomura, Elisabeth C. Sturm-Inwald, Mikiyas Amare Getu, Brigitte Bliem, Guro Astrup, Ofir Morag, Yuichiro Kikawa, Karin Kuljanic, Nora Nevries, Mirjam Sprangers, Neil K. Aaronson, Parisa Sinai, Krzysztof Tomaszewski, Razvan Galalae, Thierry Conroy, Francois Duhoux, Wei-chu Chie, Galina Velikova, on behalf of the EORTC Quality of Life Group and Breast Cancer Group
Updated efficacy and safety of HLX02 versus reference trastuzumab in metastatic HER2-positive breast cancer: A randomized phase III equivalence trial Wird in neuem Tab/Fenster geöffnet Binghe Xu, Qingyuan Zhang, Tao Sun, Wei Li, Yue'e Teng, Xichun Hu, Igor Bondarenko, Hryhoriy Adamchuk, Liangming Zhang, Dmytro Trukhin, Shusen Wang, Hong Zheng, Zhongsheng Tong, Yaroslav Shparyk, Futang Yang, Haoyu Yu, Jing Li, Qingyu Wang, Jun Zhu, HLX02-BC01 Investigators
Current controversies in the use of Oncotype DX in early breast cancer Wird in neuem Tab/Fenster geöffnet Pier Paolo M. Berton Giachetti, Ambra Carnevale Schianca, Dario Trapani, Antonio Marra, Angela Toss, Caterina Marchiò, Maria Vittoria Dieci, Oreste Davide Gentilini, Carmen Criscitiello, Kevin Kalinsky, Joseph A. Sparano, Giuseppe Curigliano
Radioligand Therapy in Metastatic Breast Cancer: Harnessing Precision Oncology Wird in neuem Tab/Fenster geöffnet Federica Giugliano, Elisa Giordano, Laura Gilardi, Beatrice Taurelli Salimbeni, Paola Zagami, Angela Esposito, Antonio Marra, Dario Trapani, Pier Paolo Maria Berton Giachetti, Bianca Malagutti, Théophraste Henry, Desiree Deandreis, Giuseppe Curigliano, Francesco Ceci, Carmen Criscitiello
ESMO's Journal Portfolio
While diverse in nature and in content, these journals offer ESMO members and the oncology community a highly visible platform to publish important scientific studies, and a highly credible source for educational updates. Elsevier is the proud publisher of Annals of Oncology, Immuno-Oncology and Technology (IOTECH), ESMO Open, ESMO Gastrointestinal Oncology, ESMO Real World Data and Digital Oncology, ESMO Rare Cancers, and ESMO Affiliated Journals The Breast, Lung Cancer, Cancer Treatment Reviews and Clinical Lymphoma Myeloma and Leukemia.
